Missed us at #ACR24? View our latest research in #rheumatology and #lupus #nephritis by visiting MEDICALLY, our online platform for scientific exchange, congress information, and resources.

Join Genentech at #ASH24 to hear the latest data in #hematology and explore recent advances in #leukemia, lymphoma, hemophilia, myeloma, and rare blood disorders. Have questions or insights you would like to discuss? Visit our Medical Affairs team at booth 715.

Join Genentech at #AIBD 2024 to explore the latest data in #gastroenterology and innovative approaches in the #IBD treatment landscape. Have questions or insights you would like to discuss? Visit our Medical Affairs team at booth 442.

Join Genentech at #SABCS24 to explore the latest advances in #BreastCancer and stay up-to-date on key research in breast #Oncology and #WomensHealth. Have questions or insights you would like to discuss? Visit our Medical Affairs team at booth 743.

Missed us at #ASH24? View our #hematology research by visiting MEDICALLY, our online platform for scientific exchange, congress information and resources. #hematology #leukemia

Missed us at #AIBD 2024? View our #gastroenterology research by visiting MEDICALLY, our online platform for scientific exchange, congress information and resources. #IBD

Missed us at #SABCS24? View our #BreastCancer research by visiting MEDICALLY, our online platform for scientific exchange, congress information and resources. #Oncology #WomensHealth

New Publication: TIGIT, a novel co-inhibitory immune checkpoint, has been shown to limit anti-tumor responses. Dual blockade of TIGIT and PD-L1 may lead to improved quality of anti-tumor T-cell activity and immune responses. #immunotherapy #oncology #tigit

A letter to the editor on an exploratory analysis evaluating dexamethasone premedication for bispecific antibody treatment to mitigate cytokine release syndrome in patients with R/R #LBCL. Read the letter in Haematologica to learn more #hematology #oncology #lymphoma

Discover Genentech’s latest breakthroughs at the 2025 ACTRIMS Forum. Join us as we address unmet needs in neuroimmunology with a robust collection of findings on monoclonal antibodies and BTK inhibitors for MS care. #Neuroimmunology #MultipleSclerosis #ACTRIMSForum

Don’t miss Genentech’s latest breakthroughs at the 2025 AAAAI/WAO Joint Congress. Addressing unmet needs in food allergy and CSU care, our data explore monoclonal antibody–treated IgE levels, diagnostic practices, QoL burden, and disparities in care. #FoodAllergy #CSU #AAAAI25

Don’t miss Genentech’s latest MS breakthroughs at the 2025 American Academy of Neurology Annual Meeting. Explore advances in available biomarkers, treatment impact, and disease progression in multiple sclerosis. #AANAM #Neurology #MultipleSclerosis

Discover Genentech’s latest research at the 2025 Digestive Disease Week (DDW) Annual Meeting. Explore emerging therapies in inflammatory bowel disease with the latest data on anti-TL1A antibody therapy in moderately to severely active ulcerative colitis. #DDW2025 #IBD

Discover Genentech’s latest breakthroughs at the Consortium of Multiple Sclerosis Centers (CMSC) 2025 annual meeting. Join us for insights highlighting progress in disease control, optimized dosing, and patient-centered care in multiple sclerosis. #CMSC25 #MultipleSclerosis #MS

Discover Genentech’s latest breakthroughs at ASCO 2025. Explore new insights across breast, colon, and lymphatic cancers, including developments in PIK3CA-targeted approaches, immunotherapy and bispecific antibodies. #ASCO25 #Oncology #Hematology

Discover Genentech’s latest advancements at EHA 2025. Explore new insights in lymphoma care, including findings on bispecific antibody regimens. #Hematology #Oncology #Lymphoma

Discover Genentech's latest advancements at the 2025 International Society on Thrombosis and Hemostasis Conference. Explore new insights into the evolving hemophilia A treatment landscape, including innovations in bispecific antibody–based therapies. #ISTH2025 #Hemophilia

Explore Genentech's latest advancements in lymphoma care at ICML 2025. From frontline to relapsed disease, we are unveiling new data on innovative approaches featuring bispecific antibodies and antibody–drug conjugates across challenging subtypes. #Oncology #Lymphoma #Hematology

Discover Genentech’s latest advancements at the American Diabetes Association's 85th Annual Scientific Sessions. Explore new insights in diabetes and obesity care, including findings on dual GLP-1/GIP receptor agonist therapy. #Obesity #Diabetes #ADASciSessions

EXPANDED INDICATION: An indication expansion has been approved for hospitalized pediatric COVID19 patients ≥2 years of age who are receiving systemic corticosteroids and require supplemental oxygen, invasive/non-invasive mechanical ventilation, or ECMO. #Immunology #Covid19 #FDA